Stock Price Quote

HIKAL LTD.

NSE : HIKALBSE : 524735ISIN CODE : INE475B01022Industry : Pharmaceuticals & DrugsHouse : Kalyani
BSE395.40-21.15 (-5.08 %)
PREV CLOSE ( ) 416.55
OPEN PRICE ( ) 417.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 38158
TODAY'S LOW / HIGH ( )392.25 429.00
52 WK LOW / HIGH ( )268.05 464.5
NSE395.05-21.7 (-5.21 %)
PREV CLOSE( ) 416.75
OPEN PRICE ( ) 418.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 395.05 (187)
VOLUME 860226
TODAY'S LOW / HIGH( ) 391.55 429.95
52 WK LOW / HIGH ( )267.25 464.75
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1988
Management Info
Jai Hiremath - Chairman Sameer Hiremath - Managing Director
Registered Office

Address 717 / 718,Maker Chambers-5,Nariman Point,
Mumbai,
Maharashtra-400021

Phone 022-39267100 / 62770477

Email info@hikal.com

Website www.hikal.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Road,Vikhroli West,Mumbai
Listing : BSE, NSE

NEWS

04Feb Hikal informs about submission of unau
Hikal has informed that, the Board of Directors of the Company at its me..
13Jan Hikal informs about disclosure
Hikal has informed that the Company is in receipt of a letter from Jai H..
26Dec HIKAL informs about change in management
In accordance with the provisions of Regulation 30 of the Securities and..
13Nov Hikal informs about analyst meet
Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclo..
22Jul HIKAL informs about disclosure
HIKAL has informed that it enclosed Disclosure under Regulation 30 of th..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit173695.100000000002
Gross Profit 239 954.100000000002
Operating Profit 7582693.9
Net Sales 447717846

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

TTK Healthcare (BSE)
peergroup  1233.80 (0.44%)
M.Cap ( in Cr)1743.40
Jagsonpal Pharma (BSE)
peergroup  243.55 (1.82%)
M.Cap ( in Cr)1618.11
Alivus Life Sciences (BSE)
peergroup  1034.35 (0.39%)
M.Cap ( in Cr)12688.71
Oxygenta Pharma (BSE)
peergroup  85.05 (4.70%)
M.Cap ( in Cr)314.36
Bafna Pharma (BSE)
peergroup  79.74 (4.99%)
M.Cap ( in Cr)188.64

Shareholding Pattern

PROMOTERS 68.85%
NON-INSTITUTION 21.66%
MUTUAL FUNDS/UTI 2.93%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Hikal Ltd.

Hikal Ltd. was incorporated in the year 1988. Its today's share price is 395.4. Its current market capitalisation stands at Rs 4875.31 Cr. In the latest quarter, company has reported Gross Sales of Rs. 17846 Cr and Total Income of Rs.17870.46 Cr. The company's management includes Sarangan Suresh, Ranjana S Salgaocar, Ravi Kapoor, V Ramachandra Kaundinya, Berjis Minoo Desai, Shrikrishna K Adivarekar, Shivani Bhasin Sachdeva, Amit Kalyani, Sugandha Hiremath, Sameer Hiremath, Jai Hiremath, Rajasekhar Reddy.

It is listed on the BSE with a BSE Code of 524735 , NSE with an NSE Symbol of HIKAL and ISIN of INE475B01022. It's Registered office is at 717 / 718,Maker Chambers-5,Nariman PointMumbai-400021, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Co, BSR & Co LLP, SRBC & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.